Healthcare and life sciences

Setterwalls

Praised for its ‘deep insight’ into life sciences regulation, Setterwalls’ practice handles the full gamut of SPC and patent issues, M&A, and capital markets mandates within the sector. Per Lidman leads the team from Malmö with his longstanding experience in pharma patent litigation, distribution, and licensing issue. Regulatory specialist Helena Nilsson is well placed to advise on clinical studies, market access, and classification-focused mandates, while Martin Levinsohn is recommended for his broad experience encompassing infringement and revocation actions, in addition to competition-focused mandates.

Legal 500 Editorial commentary

Testimonials

Collated independently by Legal 500 research team.

‘Very pragmatic. Direct, to the point, friendly professional people.’
‘Great team with deep insight into life sciences regulation.’
‘Helena Nilsson knows the regulatory work in detail. Lovisa Dahl Nelson is a great IP lawyer.’
‘Very agile team as well as very knowledgeable. Someone to hold hands with when problems arise. Feels truly like an internal legal department!! Covers a wide range of special knowledge within the life sciences industry so it is truly a one-stop-shop when approaching the Setterwalls life sciences team.’
‘The team's response is very quick and it very quickly and professionally gets a very good grip of the situation, and knows how to act and react in different situations.’
‘Excellent knowledge of local law and practice, availability, counsel on litigation, patent invalidation and on practical and strategic aspects linked to the Swedish law.’
‘Martin Levinsohn and Karolina Jivebäck Pap: in addition to their outstanding knowledge of the sector and of local law, they have provided advice in a timely and clear manner, with strategic outlook and full discussion of the possible scenarios.’

Key clients

Abacus Medicine
Accord Healthcare
Apoteksgruppen i Borrby nr 1 AB
Barry Callebaut
Blodtrycksdoktorn
Coala Life
Doktorse Nordic
Gbosco AB
Move & Walk Sverige AB
Cloetta
EQL Pharma
Fresenius Kabi
Gutfeeling Labs
Index Pharmaceuticals
Isofol Medical AB
Mylan
Neuraxpharm
Flerie Invest
Novo Nordisk
Orifarm
Respiratorius
Sandoz
Sever Pharma Solutions
Viatris
Zentiva
Orkla Confectionery & Snacks
Enzymatica

Work highlights

Assisting KKR in connection with the acquisition of Immedica Pharma. The investment is made through KKR Health Care Strategic Growth Fund II.
Advised Navamedic on an IP licensing and distribution arrangement with Orion Corporation concerning Flexilev in Europe.
Representing Sandoz in a patent dispute with Bayer concerning Bayer’s patent for a once-daily dosing regimen for the active ingredient rivaroxaban, which is a pharmaceutical used in the prevention and treatment of thromboembolism.